Cargando…

Immunotherapies targeting tumor vasculature: challenges and opportunities

Angiogenesis is a hallmark of cancer biology, and neoadjuvant therapies targeting either tumor vasculature or VEGF signaling have been developed to treat solid malignant tumors. However, these therapies induce complete vascular depletion leading to hypoxic niche, drug resistance, and tumor recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dianat-Moghadam, Hassan, Nedaeinia, Reza, Keshavarz, Mohsen, Azizi, Mehdi, Kazemi, Mohammad, Salehi, Rasoul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506263/ https://www.ncbi.nlm.nih.gov/pubmed/37727791 http://dx.doi.org/10.3389/fimmu.2023.1226360

Ejemplares similares

Modulation of LXR signaling altered the dynamic activity of human colon adenocarcinoma cancer stem cells in vitro
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2021)

Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2022)

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016)

T cell immunotherapy for cervical cancer: challenges and opportunities
por: Yu, Lingfeng, et al.
Publicado: (2023)

The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2020)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
por: Lin, Aifen, et al.
Publicado: (2021)

Pathological Mobilization and Activities of Dendritic Cells in Tumor-Bearing Hosts: Challenges and Opportunities for Immunotherapy of Cancer
por: Tesone, Amelia J., et al.
Publicado: (2013)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity
por: Janji, Bassam, et al.
Publicado: (2018)

Status of integrin subunit alpha 4 promoter DNA methylation in colorectal cancer and other malignant tumors: a systematic review and meta-analysis
por: Jafarpour, Sima, et al.
Publicado: (2023)

Correction to: Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
por: Yang, Jieying, et al.
Publicado: (2023)

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
por: Kouidhi, Soumaya, et al.
Publicado: (2018)

Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential
por: Bao, Lei, et al.
Publicado: (2023)

Tumor-Derived cGAMP Regulates Activation of the Vasculature
por: Campisi, Marco, et al.
Publicado: (2020)

Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
por: Chen, Long, et al.
Publicado: (2022)

The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment
por: Hendry, Shona A., et al.
Publicado: (2016)

Cold Tumors: A Therapeutic Challenge for Immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2019)

A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy
por: Duru, Gizem, et al.
Publicado: (2020)

Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors
por: Shahgolzari, Mehdi, et al.
Publicado: (2022)

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy
por: de Alencar, Viviane Teixeira L., et al.
Publicado: (2022)

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
por: Schaaf, Marco B., et al.
Publicado: (2018)

Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions
por: Visalakshan, Rahul M., et al.
Publicado: (2023)

Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy
por: Khan, Safir Ullah, et al.
Publicado: (2023)

Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy
por: Taghikhani, Adeleh, et al.
Publicado: (2020)

Current Challenges for IDO2 as Target in Cancer Immunotherapy
por: Mondanelli, Giada, et al.
Publicado: (2021)

Tumor microsatellite instability and clinicopathologic features in Iranian colorectal cancer patients at risk for Lynch syndrome
por: Zeinalian, Mehrdad, et al.
Publicado: (2015)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Editorial: Regulation of Immune Function by the Lymphatic Vasculature
por: Tamburini, Beth Ann Jiron, et al.
Publicado: (2019)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)

Opportunities and Challenges in Democratizing Immunology Datasets
por: Bhattacharya, Sanchita, et al.
Publicado: (2021)

Syphilis vaccine: challenges, controversies and opportunities
por: Ávila-Nieto, Carlos, et al.
Publicado: (2023)

Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
por: Peyraud, Florent, et al.
Publicado: (2022)

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
por: Noman, Muhammad Zaeem, et al.
Publicado: (2019)

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
por: Xu, Shumin, et al.
Publicado: (2023)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Leucocyte Trafficking via the Lymphatic Vasculature— Mechanisms and Consequences
por: Jackson, David G.
Publicado: (2019)

Immunotherapy for Glioblastoma: Current Progress and Challenges
por: Yu, Miranda W., et al.
Publicado: (2021)

The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
por: Bayati, Fatemeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rkrc6k2l9gv5helpu4nqlnp560